Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Orlic-Milacic, Marija, 2023-11-06

Class:IdInstanceEdit:9852725
_displayNameOrlic-Milacic, Marija, 2023-11-06
_timestamp2023-11-06 14:54:59
author[Person:1169272] Orlic-Milacic, Marija
dateTime2023-11-06 14:54:57
(modified)[Summation:188441] The cytoplasmic domain of EGFR contains tyrosine, serine and...
[PathwayDiagram:507988] Diagram of Signaling by EGFR, Signaling by EGFRvIII in Cancer, Signaling by Ligand-Responsive EGFR Variants in Cancer, and Signaling by Overexpressed Wild-Type EGFR in Cancer
[CandidateSet:9851390] FAM83B,(FAM83A, FAM83D) [cytosol] [Homo sapiens]
[Reaction:9851407] FAM83B, (FAM83A, FAM83D) bind EGFR [Homo sapiens]
[Summation:9851411] Both recombinant and endogenous EGFR and FAM83B form a compl...
[Complex:9851427] EGFR:FAM83B,(FAM83A, FAM83D) [plasma membrane] [Homo sapiens]
[PositiveRegulation:9851450] Positive regulation by 'EGFR:FAM83B,(FAM83A, FAM83D) [plasma membrane]'
[RegulationReference:9851451] Positive regulation by 'EGFR:FAM83B,(FAM83A, FAM83D) [plasma membrane]' FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma
[Change default viewing format]
No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2023-11-06 (9852725)